(Q41219657)

28 September 2017

1 reference

title

Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery (English)

1 reference

28 September 2017

1 reference

Rajewski RA

1

1 reference

PubMed ID

8923319

28 September 2017

Stella VJ

series ordinal

2

1 reference

PubMed ID

8923319

28 September 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

Journal of Pharmaceutical Sciences

28 September 2017

1 reference

28 September 2017

85

1 reference

28 September 2017

1142-1169

1 reference

28 September 2017

11

1 reference

Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization

28 September 2017

1 reference

7 January 2021

Cycloheptaamylose Inclusion Complexes of Barbiturates: Correlation between Proton Magnetic Resonance and Solubility Studies

1 reference

7 January 2021

Inclusion compounds of cyclodextrins

1 reference

7 January 2021

Interaction of pharmaceuticals with Schardinger dextrins. I. Interaction with hydroxybenzoic acids and p-hydroxybenzoates

1 reference

7 January 2021

The effects of cyclodextrins on the disposition of intravenously injected drugs in the rat.

1 reference

7 January 2021

Oversaturated Solutions of Drug in Hydroxypropylcyclodextrins: Parenteral Preparation of Pancratistatin

1 reference

7 January 2021

Protection of erythrocytes against hemolytic agents by cyclodextrin polysulfate

1 reference

7 January 2021

Aluminium beta-cyclodextrin sulphate as a stabilizer and sustained-release carrier for basic fibroblast growth factor

1 reference

7 January 2021

beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma

1 reference

7 January 2021

Protective effects of cyclodextrin sulphates against gentamicin-induced nephrotoxicity in the rat

1 reference

7 January 2021

A new candidate for an anti-HIV-1 agent: modified cyclodextrin sulfate (mCDS71).

1 reference

7 January 2021

Differential effects of sulfate and sulfobutyl ether of beta-cyclodextrin on erythrocyte membranes in vitro.

1 reference

7 January 2021

Safety of parenteral hydroxypropyl beta-cyclodextrin.

1 reference

7 January 2021

Hydroxypropylcyclodextrins in parenteral use. I: Lipid dissolution and effects on lipid transfers in vitro

1 reference

7 January 2021

Drug solubilizers to aid pharmacologists: amorphous cyclodextrin derivatives

1 reference

7 January 2021

Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles.

1 reference

7 January 2021

Hydroxypropylcyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans

1 reference

7 January 2021

Effect of beta-cyclodextrin on sleeping time induced by barbituric acid derivatives in mice.

1 reference

7 January 2021

Preparation, characterization, and anesthetic properties of 2-hydroxypropyl-beta-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse.

1 reference

7 January 2021

Development of Aqueous Parenteral Formulations for Carbamazepine through the Use of Modified Cyclodextrins

1 reference

7 January 2021

New injectable aqueous carbamazepine solution through complexing with 2-hydroxypropyl-beta-cyclodextrin: tolerability and pharmacokinetics after intravenous injection in comparison to a glycofurol-based formulation

1 reference

7 January 2021

Effects of beta- and gamma-cyclodextrins on the pharmacokinetic behavior of prednisolone after intravenous and intramuscular administrations to rabbits

1 reference

7 January 2021

Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis

1 reference

7 January 2021

Oral, topical and parenteral antifungal treatment with itraconazole in normal and in immunocompromised animals

1 reference

7 January 2021

Dose and time-course evaluation of a redox-based estradiol-chemical delivery system for the brain. I. Tissue distribution.

1 reference

7 January 2021

A redox-based chemical delivery system that enhances estradiol distribution to the brain: disposition studies in the rat

1 reference

7 January 2021

The Effects of a Brain-Enhanced Estradiol Delivery System on Testosterone and Androgen-Dependent Tissues. I. Dose-Response and Time-Course Evaluation

1 reference

7 January 2021

Inhibition of peripheral aromatization in the male cynomolgus monkey by a novel nonsteroidal aromatase inhibitor (R 76713)

1 reference

7 January 2021

beta-cyclodextrin derivatives, SBE4-beta-CD and HP-beta-CD, increase the oral bioavailability of cinnarizine in beagle dogs

1 reference

7 January 2021

Solubilization of thiazolobenzimidazole using a combination of pH adjustment and complexation with 2-hydroxypropyl-beta-cyclodextrin

1 reference

7 January 2021

Solubilization of a tripeptide HIV protease inhibitor using a combination of ionization and complexation with chemically modified cyclodextrins

1 reference

7 January 2021

Nasal absorption enhancement of 17 beta-estradiol by dimethyl-beta-cyclodextrin in rabbits and rats

1 reference

7 January 2021

Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine

1 reference

7 January 2021

Sustained release of buserelin acetate, a luteinizing hormone-releasing hormone agonist, from an injectable oily preparation utilizing ethylated beta-cyclodextrin

1 reference

7 January 2021

Effect of (hydroxypropyl)-beta-cyclodextrin on flux of morphine, fentanyl, sufentanil, and alfentanil through the spinal meninges of monkey.

1 reference

7 January 2021

The utility of 2-hydroxypropyl-β-cyclodextrin as a vehicle for the intracerebral and intrathecal administration of drugs

1 reference

7 January 2021

Effects of intrathecal capsaicin and an NK-1 antagonist, CP,96-345, on the thermal hyperalgesia observed following unilateral constriction of the sciatic nerve in the rat

1 reference

7 January 2021

A slow-release methotrexate formulation for intrathecal chemotherapy

1 reference

7 January 2021

Protective effects of cyclodextrins on drug-induced hemolysis in vitro

1 reference

7 January 2021

Effects of cyclodextrins on chlorpromazine-induced haemolysis and central nervous system responses

1 reference

7 January 2021

Alleviation of prochlorperazine-induced primary irritation of skin by cyclodextrin complexation

1 reference

7 January 2021

[Improvement of local irritation induced by intramuscular injection of tiamulin by cyclodextrin complexation]

1 reference

7 January 2021

[Protective effects of cyclodextrin on the local irritation induced by aqueous preparations of flurbiprofen]

1 reference

7 January 2021

Preliminary safety evaluation of parenterally administered sulfoalkyl ether beta-cyclodextrin derivatives

1 reference

7 January 2021

The effect of parenterally administered cyclodextrins on cholesterol levels in the rat.

1 reference

7 January 2021

Cyclodextrins as carriers of cholesterol and fatty acids in cultivation of mycoplasmas.

1 reference

7 January 2021

Severe hypervitaminosis A in siblings: evidence of variable tolerance to retinol intake

1 reference

7 January 2021

Behavior and physiological effects of supplemental episodes of testosterone, its precursors and metabolite in rats

1 reference

7 January 2021

Volume regulation in cultured cells derived from human retinal pigment epithelium

1 reference

7 January 2021

Chemical stabilization of a vasoactive S-nitrosothiol with cyclodextrins without loss of pharmacologic activity

1 reference

7 January 2021

Possible Application to Medium-term Organ Bioassays for Renal Carcinogenesis Modifiers in Rats Treated with N-Ethyl-N-hydroxyethylnitrosamine and Unilateral Nephrectomy

1 reference

7 January 2021

Studies on antiplatelet effect of OP-41483, a prostaglandin I2 analog, in experimental animals. I. Effect on platelet function and thrombosis

1 reference

7 January 2021

Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery.

1 reference

7 January 2021

Application of molecular encapsulation for toxicology studies: comparative toxicity of p-Chloro-alpha, alpha, alpha-trifluorotoluene in alpha-cyclodextrin vehicle versus corn oil vehicle in male and female Fischer 344 rats and B6C3F1 mice

1 reference

7 January 2021

Effect of the interaction of drug-beta-cyclodextrin complex with bile salts on the drug absorption from rat small intestinal lumen

1 reference

7 January 2021

Effect of cyclodextrins on biological membrane. II. Mechanism of enhancement on the intestinal absorption of non-absorbable drug by cyclodextrins

1 reference

7 January 2021

Theoretical studies on the structures of natural and alkylated cyclodextrins

1 reference

7 January 2021

Differential elimination of synthetic butyric triglycerides in vivo: a pharmacokinetic study.

1 reference

7 January 2021

Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice

1 reference

7 January 2021

Effect of hydroxypropyl-beta-cyclodextrin on efficacy of oral itraconazole in disseminated murine cryptococcosis

1 reference

7 January 2021

Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis

1 reference

7 January 2021

Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) from three formulations of the prodrug bis(pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeys

1 reference

7 January 2021

Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of beta-cyclodextrin derivatives on alpha-chymotryptic degradation and enteral absorption of insulin in rats

1 reference

7 January 2021

Differential effects of modified beta-cyclodextrins on pharmacological activity and bioavailability of 4-biphenylacetic acid in rats after oral administration

1 reference

7 January 2021

Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes

1 reference

7 January 2021

Improvement of ursodeoxycholic acid bioavailability by 2-hydroxypropyl-β-cyclodextrin complexation in healthy volunteers

1 reference

7 January 2021

Bioequivalence of a 17β-Estradiol Hydroxypropyl-β-Cyclodextrin Complex in Postmenopausal Women

1 reference

7 January 2021

Sublingual administration of testosterone-hydroxypropyl-beta-cyclodextrin inclusion complex simulates episodic androgen release in hypogonadal men.

1 reference

7 January 2021

Hydrophilic Cyclodextrin Derivatives Enable Effective Oral Administration of Steroidal Hormones

1 reference

7 January 2021

Pharmacokinetics of dipyridamole-β-cyclodextrin complex in healthy volunteers after single and multiple doses

1 reference

7 January 2021

Improved bioavailability from a spironolactone beta-cyclodextrin complex

1 reference

7 January 2021

Pharmacokinetics and pharmacodynamics of cicaprost in healthy volunteers after oral administration of 5 to 20 micrograms.

1 reference

7 January 2021

Oral bioavailability of CHF1194, an inclusion complex of piroxicam and beta-cyclodextrin, in healthy subjects under single dose and steady-state conditions

1 reference

7 January 2021

Peracylated beta-cyclodextrins as novel sustained-release carriers for a water-soluble drug, molsidomine

1 reference

7 January 2021

[Development and pharmaceutical evaluation of hydrophobic cyclodextrin derivatives as modified-release drug carriers]

1 reference

7 January 2021

In-vivo and in-vitro evaluations of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcelluloses in dogs

1 reference

7 January 2021

In-vivo and in-vitro correlation for delayed-release behaviour of a molsidomine/O-carboxymethyl-O-ethyl-beta-cyclodextrin complex in gastric acidity-controlled dogs.

1 reference

7 January 2021

Enhancement of 4-biphenylacetic acid bioavailability in rats by its beta-cyclodextrin complex after oral administration.

1 reference

7 January 2021

Placebo-controlled comparison of piroxicam-beta-cyclodextrin, piroxicam, and indomethacin on gastric potential difference and mucosal injury in humans

1 reference

7 January 2021

Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration

1 reference

7 January 2021

The effect of a modified beta-cyclodextrin, SBE4-beta-CD, on the aqueous stability and ocular absorption of pilocarpine

1 reference

7 January 2021

Beta-cyclodextrins enhance bioavailability of pilocarpine

1 reference

7 January 2021

In vitro corneal permeability of diclofenac sodium in formulations containing cyclodextrins compared to the commercial product voltaren ophtha

1 reference

7 January 2021

Influence of vehicle and anterior chamber protein concentration on cyclosporine penetration through the isolated rabbit cornea

1 reference

7 January 2021

Effect of 2-hydroxypropyl-beta-cyclodextrin on the ocular absorption of dexamethasone and dexamethasone acetate

1 reference

7 January 2021

Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits

1 reference

7 January 2021

Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits

1 reference

7 January 2021

Sulfobutyl ether beta-cyclodextrin (SBE-beta-CD) in eyedrops improves the tolerability of a topically applied pilocarpine prodrug in rabbits

1 reference

7 January 2021

Ocular absorption and irritation of pilocarpine prodrug is modified with buffer, polymer, and cyclodextrin in the eyedrop

1 reference

7 January 2021

Modified beta-cyclodextrin (SBE7-beta-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits

1 reference

7 January 2021

Inclusion complexation of p-hydroxybenzoic acid esters with 2-hydroxypropyl-beta-cyclodextrins. On changes in solubility and antimicrobial activity

1 reference

7 January 2021

Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations

1 reference

7 January 2021

Effects of absorption enhancers on rat nasal epithelium in vivo: release of marker compounds in the nasal cavity

1 reference

7 January 2021

Improvement of nasal bioavailability of luteinizing hormone-releasing hormone agonist, buserelin, by cyclodextrin derivatives in rats

1 reference

7 January 2021

The effect of cyclodextrins on the stability of peptides in nasal enzymic systems.

1 reference

7 January 2021

Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits

1 reference

7 January 2021

Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats

1 reference

7 January 2021

Interspecies differences in the nasal absorption of insulin

1 reference

7 January 2021

Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations

1 reference

7 January 2021

Absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and blood leukocyte dynamics following intranasal administration in rabbits

1 reference

7 January 2021

Epithelial transport and bioavailability of intranasally administered human growth hormone formulated with the absorption enhancers didecanoyl-L-alpha-phosphatidylcholine and alpha-cyclodextrin in rabbits

1 reference

7 January 2021

Enzyme immunoassay of human fibroblast interferon after intranasal administration with several excipients in rabbits

1 reference

7 January 2021

Bioavailability of leuprolide acetate following nasal and inhalation delivery to rats and healthy humans

1 reference

7 January 2021

Biochemical studies of metalloendoprotease activity in the spermatozoa of three mammalian species

1 reference

7 January 2021

Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics

1 reference

7 January 2021

Intranasal administration of estradiol in combination with progesterone to oophorectomized women: a pilot study

1 reference

7 January 2021

Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837)

1 reference

7 January 2021

Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository

1 reference

7 January 2021

A study of the percutaneous absorption-enhancing effects of cyclodextrin derivatives in rats

1 reference

7 January 2021

Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits

1 reference

7 January 2021

Modification of rectal absorption of morphine from hollow-type suppositories with a combination of alpha-cyclodextrin and viscosity-enhancing polysaccharide

1 reference

7 January 2021

[Effect of inclusion complexation of decanoic acid with alpha-cyclodextrin on rectal absorption of cefmetazole sodium suppository in rabbits]

1 reference

7 January 2021

Identifiers

DOI

10.1021/JS960075U

1 reference

28 September 2017

1 reference

PubMed ID

8923319